What Testosterone Level Qualifies for TRT?

Last updated: October 1, 2026

Major guideline, lab and insurer lines in one place — and what each one actually means.

By TRT Provider Guide · Last verified: September 2026 · Editorial research; not clinician-reviewed · Educational information, not medical advice

TRT Provider Guide may earn compensation through certain provider links elsewhere on the site; that does not make this page a paid placement or provider recommendation. See our affiliate disclosure.

---

What testosterone level qualifies for TRT? No number qualifies you by itself. The American Urological Association (AUA) uses total testosterone below 300 ng/dL (about 10.4 nmol/L) as a reasonable cutoff that supports diagnosis, together with two separate early-morning tests and compatible symptoms or signs. Your lab, free testosterone when indicated, insurer and clinician may apply different rules.

That last part is the one nobody tells you. We opened 26 guideline, laboratory, insurer and government documents on 30 September 2026 and put every qualifying line side by side. They do not all answer the same question, and some use different numeric or documentation rules. One of those differences might be the reason you were told no.

This page is for you if: you have a testosterone number, or you're about to get one, and you've heard three different answers about what it means.

It's not for you if: you want a dose, a way to push a number up or down before a test, or testosterone for anyone under 18. We won't help with those.

The three numbers to know:

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

---

What testosterone level qualifies for TRT — is 300 ng/dL the real cutoff?

Answer: No single level qualifies you by itself. The American Urological Association (AUA) calls total testosterone below 300 ng/dL "a reasonable cut-off" in support of diagnosis, while the Endocrine Society's July 2026 statement describes a common clinical threshold near 300 ng/dL; both frameworks still require compatible symptoms or signs and confirmation with repeat testing.

Here's the rule the AUA actually uses, in three parts. ^[1]

1. The number. Total testosterone below 300 ng/dL.
2. The confirmation. Two separate tests, both taken early in the morning. This is the AUA's strongest-graded recommendation on diagnosis.
3. The body. Symptoms or signs that fit low testosterone.

Under the AUA framework, the number is only one part of the diagnosis. A single low result, or symptoms without consistently low testing, is not enough.

Total testosterone is all the testosterone in your blood, both the part stuck to proteins and the part floating free. It's the number on most lab reports and the one every line on this page refers to unless we say otherwise.

What counts as symptoms? The big trial that drove the 2025 FDA label change, called TRAVERSE, enrolled men with at least one of these: lower sex drive, fewer spontaneous erections, low energy, low mood, loss of body hair or less need to shave, or hot flashes. ^[25] Be honest with yourself about the middle two. Tiredness and low mood have a lot of causes, and poor sleep, stress and depression top the list.

The Endocrine Society's 2026 statement uses the same frame: at least two early-morning, fasting tests, a clinician making the call, and accurate measurement of both total and free testosterone. ^[3]

Why 299 and 301 aren't different universes

A line has to go somewhere. But your testosterone moves from hour to hour and day to day, and lab methods don't all read the same sample the same way. A 295 and a 310 from the same man a week apart is normal biology. Neither one decides anything alone. That's exactly why the guideline asks for two tests.

One number, four different questions

"Qualify" means different things depending on who's asking. Your number answers one question at a time.

If you've heard three different numbers from three different people, you're not confused. The people drawing the line really do disagree. Here's the whole list.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

---

Who draws the line? Every qualifying number in one table

Answer: Guidelines, laboratories, insurers, Medicare contractors and research trials do not all use the same line. Many of the U.S. policies we checked use 300 ng/dL, while major lab reference ranges start lower, the 2026 European urology guideline uses 12 nmol/L (about 346 ng/dL), and some payer policies use different age- or plan-specific criteria. We checked 26 documents on 30 September 2026.

This is the table we couldn't find anywhere else, so we built it. Each row links to the document it came from. To convert: ng/dL ÷ 28.84 = nmol/L.

Medical guidelines and the FDA

Note the Endocrine Society's 264. It's often quoted as "the new cutoff." It isn't. It's the bottom of a reference range for healthy young men. The same society's 2026 statement still points to about 300 for diagnosis. ^[2][3]

Laboratory "normal" flags

Insurers and government health plans

Research

Three things jump out:

1. Many lines sit at 300. A result below 300 on two proper morning tests fits the AUA's numeric benchmark and several U.S. coverage policies we checked, but symptoms, cause, safety and plan-specific rules still matter.
2. Labs flag lower than guidelines. That creates a band where your report says "normal" and the guideline says "low." More on that below. It's the single biggest source of confusion we see.
3. Some insurers use no number at all. Aetna, Cigna, Express Scripts and both Medicare contractors lean on "the lab's range." That wording matters more than you'd think.

How we built this: we chose the guidelines U.S. clinicians rely on most, the three largest reference labs, and every insurer or government policy we could open in full on 30 September 2026. These are examples, not every plan in the country. Your plan's own policy is the one that counts.

Want the lab-method detail behind these ranges? See TRT bloodwork reference ranges: 4 labs vs. 3 guidelines.

---

Where does my number land?

Answer: Find your total testosterone in the bands below to see how the published rules differ. A result under 150 ng/dL can matter in the evaluation of severe secondary hypogonadism, while the 264–299 band is especially confusing because some lab reference ranges can label it normal even though it falls below the AUA's 300 ng/dL benchmark. A number alone still does not diagnose testosterone deficiency or determine treatment.

Type your number, your lab and your insurance type into the checker to see every line at once. It works in ng/dL or nmol/L. It's free and educational, and it doesn't tell you whether you qualify. Only a clinician can do that.

Early-morning total testosterone, from a blood draw in a vein:

This table summarizes published rules. It isn't a diagnosis and it can't read your lab report for you.

Same number, different verdicts

These are made-up examples to show how the rules collide. They aren't patient stories.

Example 1: age 34, 280 ng/dL twice, both at 8 a.m., at Labcorp, with low sex drive.

• AUA: both results meet the AUA's numeric benchmark; with compatible symptoms, the repeated morning results support the diagnosis.
• His lab report: "normal." Labcorp's floor is 264.
• UnitedHealthcare: meets the line (under 300).
• Cigna: requires both results to be low by the lab's own range. His aren't.

Same man. Same blood. Opposite answers.

Example 2: age 72, 250 ng/dL twice, with symptoms, insured by Anthem.

• AUA: low.
• Endocrine Society: its 2026 statement says diagnosis works the same way at any age. ^[3]
• Anthem: requires under 200 after 70. He doesn't meet it.

Example 3: age 27, 380 ng/dL, one afternoon finger-prick test.

• Guidelines and fixed-threshold policies summarized here: the 380 result is above their numeric starting lines.
• The test itself: an afternoon finger-prick is not equivalent to the morning serum/plasma testing specified by the major guidelines and many payer policies. It should not be treated as a definitive diagnostic result.

Quick unit check: 300 ng/dL = 10.4 nmol/L · 264 = 9.2 · 346 = 12.0 · 200 = 6.9 · 150 = 5.2. For anything else, use our testosterone unit converter.

---

My lab says "normal" but I'm under 300. Which one is right?

Answer: The two numbers answer different questions. A laboratory reference interval depends on its assay and reference population, while the AUA uses below 300 ng/dL as a diagnostic benchmark that must be combined with repeat morning testing and symptoms or signs. That is why a result between 264 and 299 can print as normal on some reports while still falling below the AUA benchmark.

This one frustrates men constantly. You're not misreading anything. You're looking at two definitions of the same word.

A reference range is the interval a laboratory reports for its method and reference population. A clinical cutoff is a decision point used inside a diagnostic framework. It is not, by itself, a treatment order. Here's how far apart they sit:

The lab that moved its own line

Here's a detail we found in Labcorp's own documentation. Until 17 July 2017, its adult male range was 348–1,197 ng/dL. It then switched to 264–916 after aligning its test with the CDC's reference method. ^[6]

So a man who tested at 320 in 2016 got a "low" flag. The same 320 today prints as normal at the same lab. His body didn't change. The ruler did.

Why labs can disagree about the same blood

Labs use different machines and methods. Some use an immunoassay, a common antibody-based test. Others use mass spectrometry (LC-MS/MS), a more specific method. The Endocrine Society's 2026 statement warns that with tests that aren't standardized, the same blood sample can read low at one lab and normal at another. It recommends tests certified through the CDC's Hormone Standardization Program. ^[3]

The insurance twist

This is where the gap stops being academic.

• "Below 300" wording. UnitedHealthcare, Anthem, FEP Blue, TRICARE and Texas Medicaid write their rule this way. A 280 counts. ^{[9][14][16][17][19]}
• "Low by the lab's range" wording. Cigna's policies require both tests to be "low, as defined by the normal laboratory reference values." Express Scripts uses the same template. A 280 at Labcorp doesn't count, because Labcorp's floor is 264. ^[11][13]
• Aetna. Its policy adds "or current practice guidelines." That gives a 280 a path the Cigna wording doesn't. ^[10]

That's our reading of the policy wording, and plans can apply their rules differently. But if you're in that band and insured, ask your plan which wording applies before your doctor submits anything.

Ask for this on your next test

• An early-morning draw; several guidelines and policies specify a morning window, often before 10 a.m.
• Fasting when the ordering guideline, clinician or payer requires it; the Endocrine Society recommends morning fasting testing
• A standard laboratory blood test using the method your clinician and payer accept
• The same lab and method for repeat testing when practical, especially if results are borderline
• A CDC-certified testosterone assay when available
• Free testosterone, by equilibrium dialysis or an accurate calculation, when total testosterone is near the lower limit or SHBG may be altered

---

Do I need two tests, and what time should I test?

Answer: The AUA recommends two total testosterone tests on separate occasions, both early in the morning, and the Endocrine Society also calls for confirmation with repeat morning fasting testing. Testosterone varies across the day and can be affected by food, illness and assay method, so one isolated result can misrepresent the person's usual level.

One test is a clue. Two tests is evidence. Here's what each rulebook asks for:

Sources: ^{[1][3][4][5][14][20][25]}

What one meal did in a study

In a study of 60 men with normal testosterone, a mixed meal dropped total testosterone by about 123 ng/dL at its lowest point. 56% of them briefly fell below 300. ^[27] These were men with normal levels. So yes, what you eat before the draw can matter.

Other things that can throw off a result

• Being sick. A cold, the flu or a recent illness can lower testosterone for a while. Tell the clinician and ask whether to wait.
• Night shifts or odd sleep. "Morning" means soon after you wake up for your normal day. Tell the person ordering the test when you actually sleep.
• A finger-prick home kit. It can be a useful start. But ask whether the clinician and your insurer will accept it, because several rulebooks above specify a blood draw from a vein. Our comparison of at-home vs. lab testosterone tests covers the tradeoffs.

Need a test? See where to get a testosterone test and what it costs.

---

Not sure whether your next step is repeat testing, primary care, urology, endocrinology, reproductive urology, or an online clinic? Use TRT Provider Guide's Find My TRT Path tool to map the questions to ask and the care route that fits your situation. The tool is educational and non-diagnostic; it does not determine whether you qualify for TRT or guarantee a prescription.

---

Does the qualifying level change with age?

Answer: The AUA does not publish separate age-specific diagnostic cutoffs, and the Endocrine Society said in July 2026 that the approach and definition of hypogonadism are the same at any age. Coverage rules can still vary by plan and age, and researchers have proposed higher age-specific cutoffs for younger men that major U.S. guidelines have not adopted.

If you're over 70: check your insurer's line

Anthem and Excellus BCBS both require total testosterone below 200 ng/dL for members over 70, and below 300 for everyone else. ^[14][15]

That's a real gap between a clinical guideline and a coverage rule. A 72-year-old with two morning results at 250 ng/dL meets the AUA's numeric benchmark, but a plan using an under-200 age rule could still deny coverage on that criterion.

Other plans handle age another way:

• Aetna's cypionate policy excludes it. Age-related or "late-onset" low testosterone is treated as experimental, investigational or unproven. ^[10]
• Medicare's Palmetto GBA rules exclude it too. Hypogonadism due to aging isn't covered. ^[20]

If you're older and insured, get the plan's written criteria first.

On the clinical side, the Endocrine Society's guideline advises against routinely treating every man 65 or older who has low levels. It favors a case-by-case decision after a frank talk about risks and benefits. ^[2]

About the June 2026 FDA request. FDA requested class-wide label updates in June 2026, including removal of the limitation-of-use statement that safety and effectiveness in age-related hypogonadism had not been established. ^[29] That labeling change does not itself rewrite a clinical guideline or force an insurer to cover age-related hypogonadism; Aetna's current testosterone policies still list age-related or late-onset hypogonadism as excluded or unproven. ^[10]

If you're under 40: why 350 can feel so wrong

A 2022 study led by researchers at the University of Michigan looked at nearly 1,500 men aged 20 to 44 from national survey data. It proposed higher age-specific cut-offs: 409 ng/dL at 20–24, 413 at 25–29, 359 at 30–34, 352 at 35–39 and 350 at 40–44. ^[26]

Their point was that one cutoff may not describe the distribution seen in younger men. The study does not show that a 26-year-old at 360 ng/dL has testosterone deficiency or that testosterone explains his symptoms.

But be clear on what this is. It's a research proposal, based on the middle of the normal spread in healthy young men. The AUA hasn't adopted it, and no insurer we checked uses it. What it's good for is starting a better conversation with a urologist about why your level is where it is.

For young men, that "why" matters most. Low testosterone in your 20s or 30s needs a cause found, not just a number topped up. That's where tests like LH (luteinizing hormone) and FSH (follicle-stimulating hormone) come in. They're the pituitary gland's signals to the testicles, and they help show whether the problem starts in the testicles or in the brain.

For population averages by decade, see testosterone levels by age.

---

Can I get TRT at 350, 400 or higher?

Answer: A total testosterone result of 350 or 400 ng/dL does not meet the AUA's below-300 benchmark, but that number still should not be interpreted alone. The Endocrine Society recommends checking free testosterone when total testosterone is near the lower limit or a condition alters SHBG, while clinicians also look for other explanations for the symptoms and apply the exact payer or product rules involved.

If you're at 350 and feel lousy, the symptoms are real. Borderline numbers are where most men feel brushed off. Here's what a careful evaluation actually does with a number like yours.

Step 1: Look at free testosterone and SHBG

SHBG (sex hormone-binding globulin) is a protein that grips testosterone tightly. Free testosterone is the small share that isn't attached to anything.

• High SHBG can hide low free testosterone behind a normal-looking total.
• Low SHBG, which is common with obesity and type 2 diabetes, can do the opposite. Your total looks low while your free testosterone is fine.

The Endocrine Society recommends checking free testosterone when total testosterone sits near the lower limit or when a condition affects SHBG. It should be measured by equilibrium dialysis or calculated from total testosterone, SHBG and albumin. ^[2]

Insurers notice this too. UnitedHealthcare and Texas Medicaid accept a single calculated free or bioavailable result below 50 pg/mL when a condition that alters SHBG is present. UnitedHealthcare names thyroid disorders, HIV, liver disease, diabetes and obesity. ^[9][17]

For reference, the Quest-performed free testosterone test in Mayo's catalog lists a normal adult range of 35–155 pg/mL for ages 18 to 69. ^[7] Ranges vary by method, so don't compare your number with a range from a different lab. Our free testosterone calculator shows how the calculated number works.

Step 2: Look for the other causes

Fatigue, low mood and poor focus can come from almost anything. A good workup checks the usual suspects:

• sleep apnea and short sleep
• weight
• thyroid
• depression
• heavy drinking
• opioids and some other medicines

The Endocrine Society's 2026 statement says that when low testosterone is tied to excess weight and no other cause is found, weight loss is typically first-line treatment. ^[3] We know that's not what you wanted to read. It's in here because it's true.

Step 3: Don't let symptoms replace the diagnostic work

Symptoms matter, but they are not a substitute for accurate testing. The Endocrine Society's 2026 statement says symptoms alone are not diagnostic and calls for at least two early-morning fasting testosterone tests, while also asking clinicians to look for reversible contributors such as obesity and certain medications. ^[3]

That is the frustrating part of a borderline result: there may not be one fast answer. The useful next step is to make sure the testing and the search for other causes are complete before treating one number as the whole story.

Borderline and not sure what to do next? Use Find My TRT Path to map the questions and care setting first.

Educational note: we're not saying anyone at 350 does or doesn't need treatment. That's a clinician's call, made with the full history and appropriate testing.

---

What if my testosterone is very low — under 150 or 200?

Answer: Very low testosterone deserves a cause-focused evaluation, but 150 ng/dL is not an automatic MRI or treatment rule. The Endocrine Society says pituitary imaging should be considered in severe secondary hypogonadism (for example, T <150 ng/dL), panhypopituitarism, persistent hyperprolactinemia, or symptoms/signs of a pituitary mass; LH, FSH and prolactin help determine whether that pathway fits. ^[2]

Hypogonadism means the testicles aren't making enough testosterone. It comes in two main types:

• Primary: the problem is in the testicles. The brain shouts louder, so LH and FSH run high.
• Secondary: the problem is in the brain's signal from the pituitary or hypothalamus. LH and FSH run low or normal.

The type matters because the cause might need its own treatment. And a pituitary problem is not something a testosterone subscription fixes. The AUA also recommends checking prolactin, a pituitary hormone, when testosterone is low and LH is low or normal. ^[1][2]

Get urgent care or call 911 for sudden vision loss, a sudden severe headache, chest pain, trouble breathing or signs of a stroke. Don't wait on a hormone appointment.

Signs that point to a specialist, not an online intake:

• headaches or changes in vision
• milky discharge from the nipples, or breast growth
• very small or soft testicles
• loss of smell
• a result under 150 ng/dL with low/normal LH or other evidence suggesting secondary hypogonadism

Not sure who to see? Compare a urologist vs. an endocrinologist for low testosterone, or map the specialist route with Find My TRT Path.

---

What testosterone level does insurance require for TRT?

Answer: Most insurers we checked want two early-morning total testosterone results below 300 ng/dL, or below your lab's range, plus a qualifying diagnosis. Some plans draw the line elsewhere: Anthem uses under 200 after age 70, and Humana's Indiana Medicaid plan accepts 350 or less. Several plans also exclude "age-related" low testosterone.

Here are the rules that matter most, side by side:

Sources: ^{[9][10][11][14][16][17][18][20]}. Checked 30 September 2026.

Compounded vs. FDA-approved. Compounded drugs are not FDA-approved, which means FDA does not verify their safety, effectiveness or quality before they are marketed. ^[31] A compounded testosterone preparation is therefore not interchangeable, as a regulatory claim, with an FDA-approved testosterone product. UnitedHealthcare's policy calls compounded hormone products not proven or medically necessary. ^[9] Get the exact product name before you assume anything about coverage.

If you want your insurance plan to pay, start with the plan's written policy for the exact product and an in-network clinician when available. Our list of TRT providers that take insurance is the right next page for that decision.

Three questions to ask your plan before your doctor submits:

1. "What testosterone number and test timing does my plan require for [the exact drug]?"
2. "Is it a fixed number, or 'below the lab's reference range'?"
3. "Is age-related or late-onset low testosterone excluded?"

---

I want kids someday. Does that change anything?

Answer: It changes which treatment makes sense, not what your number means. Testosterone therapy can lower sperm production, and the joint AUA and American Society for Reproductive Medicine guideline advises against testosterone alone for men who want children now or later. Talk to a reproductive urologist before you start anything.

Testosterone from outside the body tells your brain to turn down the signals that drive spermatogenesis, the process of making sperm. ^[30] We can't tell you that testosterone will make you infertile, and we can't promise it won't. Nobody can promise fertility comes back on a set timeline.

You'll see clomiphene, enclomiphene and hCG marketed as "fertility-friendly." They are not TRT, and they aren't interchangeable with it or with each other:

• Clomiphene is FDA-approved for ovulatory dysfunction in women. Using clomiphene in men is off-label.
• Enclomiphene has no FDA-approved drug product containing enclomiphene as the active ingredient. ^[34]
• hCG (human chorionic gonadotropin) is a prescription gonadotropin, not testosterone. FDA materials identify approved hCG products for certain forms of secondary hypogonadism, but whether it fits a fertility plan depends on the diagnosis and specialist judgment. ^[34]

A reproductive specialist has to match any treatment to the cause.

See TRT and fertility, or use Find My TRT Path to map a fertility-first care route.

---

I have two low morning tests and symptoms. What's next?

Answer: Two low morning results plus compatible symptoms or signs meet key diagnostic elements in the AUA framework, but they do not guarantee that TRT is appropriate or that a prescription will be issued. A clinician still evaluates the cause, fertility plans, hematocrit and other safety factors, then decides whether treatment—and which care setting—fits.

Tick these boxes first

• ☐ Two separate early-morning testosterone results have been reviewed in context
• ☐ Symptoms or signs fit the clinical evaluation
• ☐ Fertility plans have been discussed before treatment
• ☐ The clinician has reviewed hematocrit and other relevant safety risks
• ☐ The cause of low testosterone has been considered, not just the number
• ☐ Any online clinician is authorized to care for you where you are located

Checking these boxes does not mean you qualify for a prescription. It means the evaluation has moved beyond a single number and the next decision belongs with a licensed clinician who can review your full history.

Testosterone is a Schedule III controlled substance and requires a valid prescription. ^[32] DEA and HHS have extended specified federal telemedicine flexibilities for prescribing controlled medications through 31 December 2026; the temporary rule does not override state law, licensing rules or the other requirements that apply to the prescriber and patient. ^[33]

Choose the care route before you choose a company

If the diagnostic work is complete, the next decision is not automatically "which TRT subscription?" It is which care setting can safely answer the remaining question.

The right provider is not the same for every person. A paid intake, questionnaire or lab package does not establish a diagnosis, clear a contraindication, or guarantee a testosterone prescription.

Two low morning tests and symptoms, but still unsure which care route fits? Use TRT Provider Guide's Find My TRT Path tool →

---

What we actually verified

Checked 30 September 2026.

Guidelines and regulators. We opened:

• the AUA testosterone deficiency guideline page
• the Endocrine Society's 2018 guideline and its 16 July 2026 statement
• the European Association of Urology's 2026 summary
• the VA Criteria for Use (March 2025)
• the HHS announcement of 18 June 2026
• the AndroGel 1.62% label

Labs. We read the reference-range documents for Labcorp, Quest (via Mayo Clinic Laboratories' catalog) and Mayo Clinic Laboratories.

Insurers and government plans. We opened each policy listed in the tables. That covers UnitedHealthcare, Aetna, Aetna Better Health, Cigna, Express Scripts, Anthem, Excellus BCBS, FEP Blue, Texas Medicaid, Humana Healthy Horizons in Indiana, TRICARE, two Medicare contractors, Kaiser Permanente Northwest and Health Net. We re-checked the figures behind this page's biggest findings a second time: Anthem's age split, Cigna's wording, Humana Indiana's 350 and FEP's 800.

What we couldn't confirm from the public materials used here:

• Humana's commercial and Medicare drug-plan criteria
• UnitedHealthcare's pharmacy-benefit rules for gels

What we didn't do: examine anyone, read anyone's labs, submit an insurance claim or enroll with a provider. A clinician has not reviewed this page.

Our process is documented in How We Review TRT Providers.

---

Frequently asked questions

What level of testosterone qualifies for TRT?

No number qualifies you on its own. The AUA uses total testosterone below 300 ng/dL as a reasonable cutoff in support of diagnosis, together with two separate early-morning measurements and compatible symptoms or signs; payer rules can use different thresholds or laboratory-reference wording.

Is 264 or 300 the real cutoff?

Both show up, but they mean different things. 264 ng/dL is the bottom of the Endocrine Society's reference range for healthy young men. 300 ng/dL is the line the AUA uses to support a diagnosis, and the Endocrine Society's 2026 statement also points to about 300.

Can I get TRT with 350 or 400 ng/dL?

A total T of 350 or 400 ng/dL is above the AUA's below-300 benchmark, but a number alone still does not finish the evaluation. When total T is near the lower limit or SHBG may be altered, the Endocrine Society recommends free-testosterone assessment with an appropriate method; clinicians also look for other causes of the symptoms.

What testosterone level is dangerously low?

There's no universal "dangerous" testosterone number. In suspected secondary hypogonadism, the Endocrine Society lists T <150 ng/dL as one reason pituitary imaging may be warranted, especially with other pituitary clues; sudden vision loss or a new severe headache needs urgent medical evaluation.

What is 300 ng/dL in nmol/L?

About 10.4 nmol/L. Divide ng/dL by 28.84 to get nmol/L. Europe's 12 nmol/L line equals about 346 ng/dL.

Does free testosterone count?

Yes, especially when total testosterone is borderline or SHBG is abnormal. Some insurers, including UnitedHealthcare, accept a calculated free or bioavailable result below 50 pg/mL in those cases.

Do home finger-prick tests count for TRT?

A home finger-prick result can be a screening result, but it may not satisfy the serum-testing method and timing required by a clinician or payer. Ask whether the result is accepted before treating it as diagnostic evidence or paying for care.

Why did my doctor say my 280 was normal?

Some major laboratory reference intervals begin below 280 ng/dL, so a 280 result can print as normal even though it is below the AUA's 300 ng/dL diagnostic benchmark. Those numbers serve different purposes, and neither one should be interpreted without the rest of the evaluation.

Does the FDA say 300 qualifies you?

No. FDA-approved labels say to confirm testosterone is below the normal range on at least two separate days, in the morning, before starting. They don't set a single national number.

Does insurance cover TRT at 300?

Not automatically. Several policies we checked use below 300 ng/dL or the laboratory's lower reference limit and require repeat morning testing, while other plans use different criteria or exclusions. Your own plan's current policy and the exact testosterone product control coverage.

What should my testosterone be once I'm on TRT?

None of the providers we checked publishes a target. Your clinician sets it. Some insurers cap renewals, for example 800 ng/dL or less at FEP Blue. See TRT bloodwork reference ranges for monitoring ranges.

Can I get TRT without a blood test?

Not for a new diagnosis under the major guidelines discussed here. Testosterone is a Schedule III controlled substance that requires a valid prescription, and the AUA and Endocrine Society diagnostic frameworks require laboratory confirmation rather than symptoms alone.

Is there a VA "criteria for use" for testosterone?

Yes. The VA publishes one. It reads results against the local lab's test and asks for two fasting tests between 8 and 10 a.m., at least a week apart.

---

Educational information, not medical advice. Call 911 for chest pain, trouble breathing, stroke symptoms or sudden vision loss.

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

---

Sources

All sources were checked on 30 September 2026 unless noted. Provider pages are provider-published information.

1. American Urological Association. Evaluation and Management of Testosterone Deficiency (2018; validity confirmed 2024).
2. Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: Endocrine Society Clinical Practice Guideline. JCEM. 2018;103:1715–1744.
3. Endocrine Society. Statement on Testosterone Replacement Therapy. 16 July 2026.
4. Corona G, et al. EAU Guidelines on Sexual and Reproductive Health: 2026 recommendations for measurement and biochemical confirmation of hypogonadism. European Urology Focus, 2026.
5. U.S. Department of Veterans Affairs. Testosterone Replacement Therapy in Males: Criteria for Use. March 2025.
6. Labcorp. Testosterone reference interval change (effective 17 July 2017).
7. Mayo Clinic Laboratories. Testosterone, Free (Dialysis) and Total, MS (performed by Quest Diagnostics Nichols Institute).
8. Mayo Clinic Laboratories. Testosterone, Total, Serum (LC-MS/MS).
9. UnitedHealthcare. Testosterone Replacement or Supplementation Therapy, Commercial Medical Benefit Drug Policy 2026D0076J.
10. Aetna. Clinical Policy Bulletin 1014: Testosterone Cypionate Injections.
11. Cigna. IP0351: Testosterone Products (Injectable).
12. Cigna. IP0350: Testosterone Products (Oral, Topical, Nasal).
13. Express Scripts. Testosterone (Injectable) Products Prior Authorization Policy.
14. Anthem / Elevance. Clinical Criteria CC-0026: Testosterone, Injectable.
15. Excellus BCBS. Testosterone (Testopel, Aveed, Azmiro) drug policy.
16. BCBS Federal Employee Program. Policy 5.30.033: Testosterone Injectable.
17. Texas Medicaid (HHSC). Androgenic Agents prior authorization criteria.
18. Humana Healthy Horizons in Indiana. Testosterones prior authorization request form (rev. 1 July 2026).
19. US Family Health Plan (TRICARE). Testosterone cypionate/enanthate prior authorization form.
20. CMS. Local Coverage Determination L39086: Treatment of Males with Low Testosterone (Palmetto GBA).
21. CMS. Local Coverage Determination L36538 (Noridian).
22. Kaiser Permanente Northwest. Testosterone cypionate prior authorization guideline.
23. Health Net / Centene. CP.CPA.291: Testosterone.
24. Aetna Better Health. Testosterone Agents Medicaid policy.
25. Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. New England Journal of Medicine. 2023.
26. Zhu A, et al. What Is a Normal Testosterone Level for Young Men? Rethinking the 300 ng/dL Cutoff for Testosterone Deficiency in Men 20–44 Years Old. Journal of Urology. 2022.
27. Study of a mixed meal's effect on serum testosterone in men with normal levels. Endocrine (PubMed Central PMC6445266).
28. DailyMed. AndroGel 1.62% prescribing information.
29. HHS. FDA requests updates to testosterone therapy labeling. 18 June 2026.
30. AUA/ASRM. Diagnosis and Treatment of Infertility in Men, Part II.
31. FDA. Understanding the Risks of Compounded Drugs.
32. DEA. Drug Scheduling.
33. DEA and HHS. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities. 90 FR 61301, 31 December 2025.
34. FDA. Pharmacy Compounding Advisory Committee briefing: hCG is an approved treatment option for certain secondary hypogonadism; no FDA-approved drug product contains enclomiphene citrate as the active ingredient.

---

---